Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

63
Brick-and-Mortar Takes on Amazon Prime Day Challenge: 4 Hot Picks

11h investorplace
As Amazon Prime Day is round the corner, brick-and-mortar retailers are looking for ways to compete with the astounding sales that are almost scaling near the “Black Friday” level. Brick-and-mortar retailers are coming up with an array of special offers and discounts to attract customers and lessen Amazon Prime Day’s impact.
WFM DDS TGT JWN KR AMZN SFM SCVL BBY GME WMT

64
Bricks and Mortar Take On Prime Day Challenge: 4 Hot Picks

16h zacks
As Amazon Prime Day is round the corner, brick-and-mortar retailers are looking for ways to compete with the astounding sales that are almost scaling near the “Black Friday” level. Brick-and-mortar retailers are coming up with an array of special offers and discounts to attract customers and lessen Amazon Prime Day’s impact.
WFM TGT JWN POOL AMZN SFM KR GTT SCVL GME WMT

5
GME / GameStop Corp. / BlackRock Inc. - null (Passive Investment)

2018-07-10 sec.gov
us36467w1099_070518.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 11) GAMESTOP CORP -------------------------------------------------------- (Name of Issuer) Class A Common Stock -------------------------------------------------------- (Title of Class of Securities) 36467W109 -------------------------------------------------------- (CUSIP Number) June 30, 2018 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cove
GME

5
GME / GameStop Corp. / BlackRock Inc. - null (Passive Investment)

2018-07-10 sec.gov
us36467w1099_070518.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 11) GAMESTOP CORP -------------------------------------------------------- (Name of Issuer) Class A Common Stock -------------------------------------------------------- (Title of Class of Securities) 36467W109 -------------------------------------------------------- (CUSIP Number) June 30, 2018 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cove
GME

5
GameStop: One Man's Trash Is Another Man's Treasure

2018-07-09 seekingalpha
Any buyer with cheap financing available would benefit greatly from acquiring GameStop's balance sheet and cash flows.
GME

11
CEFL With 17.2% Dividend Yield Still Attractive, But Risks Increase

2018-07-05 seekingalpha
Risks and uncertainties in the financial markets suggest that portfolios with heavy interest rate risk might consider more diversification.
CLNS CLNS.PRJ CLNS.PRI CLNS.PRH CLNS.PRG CLNS.PRE HOG CLNS.PRD GME CLNS.PRB USA CLNS.PRDCL PII BGS

7
Implied Volatility Surging for GameStop (GME) Stock Options

2018-07-03 zacks
Investors in GameStop Corp. (GME - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Jul 6, 2018 $11.50 Put had some of the highest implied volatility of all equity options today.
GOOS ABX AXTA GME ABX

1
Why is GameStop (GME) Up 12.7% Since Its Last Earnings Report?

2018-07-02 zacks
It has been about a month since the last earnings report for GameStop Corp. (GME - Free Report) . Shares have added about 12.7% in that time frame.
GME

6
GME / GameStop Corp. 8-K (Current Report)

2018-06-29 sec.gov
Document
GME

1
Summer Fun Has Just Begun at GameStop with Unbeatable Game Days Deals

2018-06-29 globenewswire
GRAPEVINE, Texas, June 29, 2018 (GLOBE NEWSWIRE) -- Beginning July 2, deals will be as hot as the summer sun at GameStop. With unmatched savings and trade offers on games, consoles, accessories, toys and apparel, there’s something for everyone during Game Days.
GME

9
Sony: The Best Bet Of Gaming Stocks

2018-06-28 seekingalpha
Sony Entertainment (SNE) has been going from strength to strength over the past two years. Much of this surging growth and more than doubling of the stock price is driven by its gaming strength. Gaming is going through a huge secular growth surge worldwide.
SNE SNEJF GME

8
GameStop: A True Low-Risk, High-Return Bargain Purchase

2018-06-27 seekingalpha
GameStop is significantly undervalued trading at roughly 4-5X free cash flow, possessing a free cash flow yield of 20-25% along with a dividend yield of 10%.
EA GME

56
Buyout Interest In GameStop Makes The Long Case Even More Compelling

2018-06-26 seekingalpha
The negative narrative for GameStop has driven valuations to rock-bottom levels even though the company has solid cash flows.
T MSFT SNE GME

12
Time to Play the Video Game ETF?

2018-06-25 zacks
In this episode of ETF Spotlight, I talked with Ted Pollak, President, EE Fund Management. Ted co-founded the ETFMG Video Game Tech ETF (GAMR - Free Report) .
EA KHC GME RCKY

20
Excitement About GameStop For The Wrong Reasons

2018-06-25 seekingalpha
Rather than committing to a deal, shareholders should focus on the immense cash generation of the business making it potentially interesting for a deal in the first place.
M GME

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

35m - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

22h - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to GME / GameStop Corp. on message board site Silicon Investor.

Fragments of Interest GameStop Corp (GME)
Judgment from Above? Microsoft: The Devices and Consumer Segment
GMED - GenoMed Inc. U.S. Microbics {BUGS} - Environmental Augmentation
SCRM: ScreamingMedia.com WHY DID THE BROKER SELL THE DOGMEAT?
DSGX E-Business- web-based supply chain managment Biogan Intl (BIGM or BIGME?)
CUSIP: 36467W109